Generate Investment Management Ltd Takes $5.33 Million Position in HCA Healthcare, Inc. $HCA

Generate Investment Management Ltd purchased a new position in HCA Healthcare, Inc. (NYSE:HCA) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 12,500 shares of the company’s stock, valued at approximately $5,328,000.

Several other hedge funds have also bought and sold shares of HCA. Ameriflex Group Inc. bought a new position in shares of HCA Healthcare in the second quarter worth about $27,000. Chung Wu Investment Group LLC bought a new stake in shares of HCA Healthcare in the second quarter worth about $27,000. Clearstead Trust LLC boosted its stake in HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after buying an additional 53 shares during the last quarter. Harbor Capital Advisors Inc. boosted its position in shares of HCA Healthcare by 82.9% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after acquiring an additional 34 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC bought a new stake in HCA Healthcare in the second quarter worth $40,000. Institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on HCA shares. Jefferies Financial Group upped their target price on shares of HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a research report on Tuesday, October 28th. Oppenheimer increased their price target on HCA Healthcare from $400.00 to $500.00 and gave the company an “outperform” rating in a report on Monday, October 27th. Sanford C. Bernstein reissued a “market perform” rating and issued a $417.00 target price on shares of HCA Healthcare in a research note on Monday, October 27th. Wall Street Zen raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 25th. Finally, The Goldman Sachs Group boosted their target price on shares of HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Fourteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $479.00.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $473.13 on Wednesday. The firm has a fifty day moving average price of $477.30 and a 200 day moving average price of $422.24. The stock has a market cap of $107.96 billion, a PE ratio of 18.29, a price-to-earnings-growth ratio of 1.40 and a beta of 1.36. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $520.00.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The company had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.HCA Healthcare’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same period in the previous year, the company posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, December 29th. Stockholders of record on Monday, December 15th were given a dividend of $0.72 per share. The ex-dividend date was Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is 11.13%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.